Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :11241
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer

Shah F D, Shukla S N, Shah P M, Shukla H K, Patel P S

Year : 2009| Volume: 46| Issue : 3 | Page no: 194-202

   This article has been cited by
1 Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level
Elham Ali Ahmed, Sohir A. Abd El-Basit, Mona A. Mohamed, Menha Swellam
Archives of Physiology and Biochemistry. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
Qing Xie,Zhijie Yang,Xuanmei Huang,Zikang Zhang,Jiangbin Li,Jianhua Ju,Hua Zhang,Junying Ma
Journal of Hematology & Oncology. 2019; 12(1)
[Pubmed]  [Google Scholar] [DOI]
3 Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
Robert B. Bednarczyk, Neha Y. Tuli, Elyse K. Hanly, Ghada Ben Rahoma, Rachana Maniyar, Abraham Mittelman, Jan Geliebter, Raj K. Tiwari
Oncotarget. 2018; 9(36): 24272
[Pubmed]  [Google Scholar] [DOI]
4 Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
Eunhye Oh,Yoon-Jae Kim,Hyunsook An,Daeil Sung,Tae-Min Cho,Lee Farrand,Seojin Jang,Jae Hong Seo,Ji Young Kim
International Journal of Cancer. 2018; 143(8): 1978
[Pubmed]  [Google Scholar] [DOI]
5 RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis
Feng Shen, Qing Guo, Qi Hu, Ailiang Zeng, Weining Wu, Wei Yan, Yongping You
Oncology Letters. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Glycosylation: a hallmark of cancer?
Bhairavi N. Vajaria,Prabhudas S. Patel
Glycoconjugate Journal. 2017; 34(2): 147
[Pubmed]  [Google Scholar] [DOI]
7 Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression
Kyle J. Isaacson,M. Martin Jensen,Nithya B. Subrahmanyam,Hamidreza Ghandehari
Journal of Controlled Release. 2017; 259: 62
[Pubmed]  [Google Scholar] [DOI]
8 Matrix metalloproteinases in Vietnamese patients with colorectal cancer
Thao Phuong Bui,Anh Ngoc Hoang,Phuong Lan Le,Bich Thi Pham,Linh Thi Tu Nguyen,Ha Minh Do,To Van Ta,Thai Hong Trinh
Oncology Letters. 2017; 13(4): 2097
[Pubmed]  [Google Scholar] [DOI]
9 The roles of miRNAs in human breast cancer and canine mammary tumor
Richard Ming Chuan Yu,Yoke Kqueen Cheah
Applied Cancer Research. 2017; 37(1)
[Pubmed]  [Google Scholar] [DOI]
10 Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation
Chia-Ming Yeh, Chiao-Wen Lin, Jia-Sin Yang, Wei-En Yang, Shih-Chi Su, Shun-Fa Yang
Oncotarget. 2016; 7(16): 21952
[Pubmed]  [Google Scholar] [DOI]
11 Plasminogen and angiostatin levels in female benign breast lesions
A. A. Tykhomyrov,I. L. Vovchuk,T. V. Grinenko
The Ukrainian Biochemical Journal. 2015; 87(5): 103
[Pubmed]  [Google Scholar] [DOI]
12 GnRH-(1–5) activates matrix metallopeptidase-9 to release epidermal growth factor and promote cellular invasion
Madelaine Cho-Clark,Darwin O. Larco,Brian R. Zahn,Shaila K. Mani,T. John Wu
Molecular and Cellular Endocrinology. 2015; 415: 114
[Pubmed]  [Google Scholar] [DOI]
13 Two Faces of TGF-Beta1 in Breast Cancer
Joanna Magdalena Zarzynska
Mediators of Inflammation. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
14 Functional Characterization of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) N- and C-Terminal Domains during Xenopus laevis Development
M. A. Nieuwesteeg,J. A. Willson,M. Cepeda,M. A. Fox,S. Damjanovski
The Scientific World Journal. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
15 Values of MMP-2 and MMP-9 in Tumor Tissue of Basal-Like Breast Cancer Patients
Sandra Radenkovic,Gordana Konjevic,Vladimir Jurisic,Katarina Karadzic,Marina Nikitovic,Kristina Gopcevic
Cell Biochemistry and Biophysics. 2013;
[Pubmed]  [Google Scholar] [DOI]
16 Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases
Dharmender Rathee,Madhavi Thanki,Satish Bhuva,Sheetal Anandjiwala,Reena Agrawal
Arabian Journal of Chemistry. 2013; 6(1): 49
[Pubmed]  [Google Scholar] [DOI]
17 Rab40b regulates MMP2 and MMP9 trafficking during invadopodia formation and breast cancer cell invasion
Abitha Jacob, Jian Jing, James Lee, Pepper Schedin, Simon M. Gilbert, Andrew A. Peden, Jagath R. Junutula, Rytis Prekeris
Journal of Cell Science. 2013;
[Pubmed]  [Google Scholar] [DOI]
18 BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
X Li,X Kong,Y Wang,Q Yang
Cell Death and Disease. 2013; 4(8): e757
[Pubmed]  [Google Scholar] [DOI]
19 Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases. 1st Cancer Update.
Rathee, D. and Thanki, M. and Bhuva, S. and Anandjiwala, S. and Agrawal, R.
Arabian Journal of Chemistry. 2013; 6(1): 49-58
[Pubmed]  [Google Scholar]
20 Pathogenetic role of matrix metalloproteinase-2 and matrixmetalloproteinase-9 in Behcetæs disease
Ganeb, S.S. and Kamal, H.M. and Fayed, A.A.
Life Science Journal. 2012; 9(3): 706-712
[Pubmed]  [Google Scholar]
21 Recent candidate molecular markers: Vitamin D signaling and apoptosis specific regulator of p53 (ASPP) in breast cancer
Patel, J.B. and Patel, K.D. and Patel, S.R. and Shah, F.D. and Shukla, S.N. and Patel, P.S.
Asian Pacific Journal of Cancer Prevention. 2012; 13(5): 1727-1735
[Pubmed]  [Google Scholar]
22 Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells
R S Price, D A Cavazos, R E De Angel, S D Hursting, L A deGraffenried
Prostate Cancer and Prostatic Diseases. 2012;
[HTML Full text]  [Google Scholar] [DOI]
23 Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue
Mohammad A. Mohammad, Ahmed A. Zeeneldin, Zakaria Y. Abd Elmageed, Ebtsam H. Khalil, Said M. E. Mahdy, Hayat M. Sharada, Sabry K. Sharawy, Abdel-Hady A. Abdel-Wahab
Molecular and Cellular Biochemistry. 2012;
[HTML Full text]  [Google Scholar] [DOI]
24 Body fluid MMP-2 as a putative biomarker in metastatic breast cancer
Noh, S. and Jung, J.-J. and Jung, M. and Kim, K.-H. and Lee, H.-Y. and Wang, B. and Cho, J. and Kim, T.S. and Jeung, H.-C. and Rha, S.Y.
Oncology Letters. 2012; 3(3): 699-703
[Pubmed]  [Google Scholar]
25 Body fluid MMP-2 as a putative biomarker in metastatic breast cancer
Oncology Letters. 2012; 3(3): 699
[Pubmed]  [Google Scholar] [DOI]
26 TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells
Luciana R Gomes, Letícia F Terra, Rosângela AM Wailemann, Leticia Labriola, Mari C Sogayar
BMC Cancer. 2012; 12(1): 26
[HTML Full text]  [Google Scholar] [DOI]
27 Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients
Irena Ranogajec, Jasminka Jakić-Razumović, Velibor Puzović, Jelka Gabrilovac
Medical Oncology. 2012; 29(2): 561
[HTML Full text]  [Google Scholar] [DOI]
28 Recent Candidate Molecular Markers: Vitamin D Signaling and Apoptosis Specific Regulator of p53 (ASPP) in Breast Cancer
Jayendra B. Patel,Kinjal D. Patel,Shruti R. Patel,Franky D. Shah,Shilin N. Shukla,Prabhudas S. Patel
Asian Pacific Journal of Cancer Prevention. 2012; 13(5): 1727
[Pubmed]  [Google Scholar] [DOI]
29 <i>MMP-9</i> expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma
Jian-Rong He, Han Qin, Ze-Feng Ren, Cui Cui, Ying Zhang, Dharshana Ranatunga, Yi-Xin Zeng, Wei-Hua Jia
Clinical Chemistry and Laboratory Medicine. 2011; 49(4): 705
[HTML Full text]  [Google Scholar] [DOI]
30 Status of research on MMPs in India
Chinnadurai Saravanan, Sushil Kumar Singh
Expert Opinion on Therapeutic Targets. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
31 Status of research on MMPs in India
Saravanan, C., Singh, S.K.
Expert Opinion on Therapeutic Targets. 2011; 15(6): 715-728
[Pubmed]  [Google Scholar]
32 Canine mammary tumours as a model to study human breast cancer: Most recent findings
Queiroga, F.L., Raposo, T., Carvalho, M.I., Prada, J., Pires, I.
In Vivo. 2011; 25(3): 455-465
[Pubmed]  [Google Scholar]
33 Research advances of MMPs and invasion and metastasis of breast cancer
Deng, X.-L. and Zhang, W.-H.
Chinese Journal of Cancer Prevention and Treatment. 2011; 18(23): 1893-1896
[Pubmed]  [Google Scholar]
34 Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer
Al-Raawi, D. and Abu-El-Zahab, H. and El-Shinawi, M. and Mohamed, M.M.
International Journal of Clinical and Experimental Medicine. 2011; 4(4): 265-275
[Pubmed]  [Google Scholar]
35 MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma
He, J.-R. and Qin, H. and Ren, Z.-F. and Cui, C. and Zhang, Y. and Ranatunga, D. and Zeng, Y.-X. and Jia, W.-H.
Clinical Chemistry and Laboratory Medicine. 2011; 49(4): 705-710
[Pubmed]  [Google Scholar]
36 Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene
Becks, L. and Prince, M. and Burson, H. and Christophe, C. and Broadway, M. and Itoh, K. and Yamamoto, M. and Mathis, M. and Orchard, E. and Shi, R. and McLarty, J. and Pruitt, K. and Zhang, S. and Kleiner-Hancock, H.E.
BMC Cancer. 2010; 10(540)
[Pubmed]  [Google Scholar]
37 Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells
Shen, Q., Lee, E.S., Pitts, R.L., Wu, M.H., Yuan, S.Y.
Molecular Cancer Research. 2010; 8(7): 939-951
[Pubmed]  [Google Scholar]
38 MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression
Woenne, E.C., Lederle, W., Zwick, S., Palmowski, M., Krell, H., Semmler, W., Mueller, M.M., Kissling, F.
Anticancer Research. 2010; 30(3): 703-712
[Pubmed]  [Google Scholar]
39 Clinical effect of neoadjuvant chemotherapy combined with pa-msha injection on breast cancer
Mao, Q., Zhang, M., Hao, X., Zhang, S., Zhang, J.
Chinese Journal of Clinical Oncology. 2010; 37(2): 117-120
[Pubmed]  [Google Scholar]
40 Matrix Metalloproteinases and Their Inhibitors: Correlation with Invasion and Metastasis in Oral Cancer
Ragini D. Singh, N. Haridas, Jayendra B. Patel, Franky D. Shah, Shilin N. Shukla, Pankaj M. Shah, Prabhudas S. Patel
Indian Journal of Clinical Biochemistry. 2010; 25(3): 250
[HTML Full text]  [Google Scholar] [DOI]
41 Tissue Inhibitor of Metalloproteinase-2 Regulates Matrix Metalloproteinase-2–Mediated Endothelial Barrier Dysfunction and Breast Cancer Cell Transmigration through Lung Microvascular Endothelial Cells
Qiang Shen, Eugene S. Lee, Robert L. Pitts, Mack H. Wu, Sarah Y. Yuan
Molecular Cancer Research. 2010; 8(7): 939
[Pubmed]  [Google Scholar] [DOI]
42 Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene
Lisa Becks,Misty Prince,Hannah Burson,Christopher Christophe,Mason Broadway,Ken Itoh,Masayuki Yamamoto,Michael Mathis,Elysse Orchard,Runhua Shi,Jerry McLarty,Kevin Pruitt,Songlin Zhang,Heather E Kleiner-Hancock
BMC Cancer. 2010; 10(1)
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow